This inventor holds 1 USPTO granted patent and 1 EPO patent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: Raquel Fernández Ginés and Her Patent on Fatty Liver Disease
Introduction
Raquel Fernández Ginés is an inventor associated with Madrid, Spain. Her patent work addresses a potential therapeutic approach to liver disease linked to chronic inflammation and oxidative stress.
Latest Patents
The available information lists one patent for Fernández Ginés: “Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease.” The invention concerns inhibitors of the NRF2-βTrCP interaction and their derivative salts. It describes their potential use against NRF2-related diseases caused by chronic inflammation and oxidative stress, with particular attention to fatty liver disease. The record provided does not establish whether this is her latest patent.
Career Highlights
Fernández Ginés is associated with Universidad Miguel Hernández de Elche and Universidad Autónoma de Madrid. Her listed patent reflects research focused on molecular targets relevant to inflammatory and oxidative-stress-related liver conditions.
Collaborations
Her listed collaborators include Antonio Cuadrado Pastor and Juan Felipe Franco González. Their names appear in connection with the patent information provided.
Conclusion
Raquel Fernández Ginés’s recorded invention explores NRF2-βTrCP interaction inhibitors as a possible approach to treating fatty liver disease, highlighting the role of collaborative research in developing therapeutic innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile